Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2136243 | Journal of Bone Oncology | 2013 | 5 Pages |
Abstract
While there were clear differences in the types of BTAs patients received, our survey showed similarity for both prostate and breast cancer patients with respect to their perceptions of the goals of therapy. Patients were interested in participating in trials of de-escalated therapy. However, given that patients receive a range of agents for varying periods of time and in different locations (e.g. hospital vs. home), the design of future trials will need to be pragmatic to reflect this.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Brian Hutton, Patricia Morretto, Urban Emmenegger, Sasha Mazzarello, Iryna Kuchuk, Christina L. Addison, Freya Crawley, Christine Canil, Shawn Malone, Scott Berry, Dean Fergusson, Mark Clemons,